1. Division of Epidemiology II, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
2. U.S. Department of Health & Human Services (HHS), Office of the Assistant Secretary for Preparedness & Response (ASPR)